
The infusion validates Slurrt Farm’s premium, millet‑based positioning in India’s fast‑growing healthy‑kids food segment and signals investor confidence despite widening losses, potentially accelerating market consolidation.
India’s children’s nutrition market is undergoing a rapid transformation, driven by rising parental awareness of sugar intake and a preference for locally sourced, nutrient‑dense ingredients. Brands that champion millets—a traditional grain gaining modern health credence—are uniquely positioned to capture this shift. Slurrp Farm’s portfolio, spanning porridges, millet pancakes, and snack mixes, aligns with the broader trend of functional foods for early childhood, offering a differentiated alternative to conventional, processed snacks.
The latest Series C extension, injecting Rs 30 crore and lifting the company’s valuation by 59% to $90 million, underscores the appetite among venture capitalists for health‑focused consumer brands. Scarlet Ventures’ modest 3.7% stake reflects a strategic bet on scaling distribution and product innovation, while the continued involvement of Anushka Sharma adds celebrity cachet and brand trust. Compared with its $7.2 million round in 2024, the valuation jump signals confidence in Slurrp Farm’s growth trajectory and its ability to monetize a premium positioning in a price‑sensitive market.
Financially, Slurrp Farm posted a 30% year‑on‑year revenue increase to Rs 95.6 crore, yet losses widened to Rs 32.7 crore, highlighting the cost pressures of rapid expansion and product development. The new capital will likely fund supply‑chain efficiencies, broaden retail footprints, and accelerate R&D for next‑generation millet offerings. If the company can convert revenue momentum into profitability, it could set a benchmark for Indian child‑focused food startups, attracting further institutional interest and potentially prompting larger incumbents to pursue similar health‑forward strategies.
Children‑focused snack brand Slurrp Farm secured Rs 30 crore (≈$3.3 million) in an extended Series C round from Scarlet Ventures, lifting its post‑money valuation to Rs 810 crore ($90 million). The funding will bolster the company's long‑term financial resources and support growth.
Comments
Want to join the conversation?
Loading comments...